EUVIMEDObjevte EUVIMED
Open access · CC BY-NC-ND 4.0

Dehydroepiandrosterone‐α‐2‐Deoxyglucoside Exhibits Enhanced Anticancer Effects in MCF ‐7 Breast Cancer Cells and Inhibits Glucose‐6‐Phosphate Dehydrogenase Activity

Hsu-Feng Liu, Shen-Chieh Chou, Sheng-Cih Huang, Tzu-Yu Huang, Po-Yun Hsiao, Feng-Pai Chou, Tung-Kung Wu

Chemical Biology & Drug Design · 2024

DOI: 10.1111/cbdd.14624 ↗

At a glance

Journal article in Chemical Biology & Drug Design, 2024. Written by Hsu-Feng Liu and 6 co-authors. Institution: Department of Biological Science and Technology, National Yang Ming Chiao Tung University, Hsin-Chu, Taiwan. Major MEDLINE topics: Antineoplastic Agents, Breast Neoplasms, Enzyme Inhibitors, Glucosephosphate Dehydrogenase. Cited 6 times so far (Crossref); 44 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: National Science and Technology Council, Taiwan.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

In the pentose phosphate pathway, dehydroepiandrosterone (DHEA) uncompetitively inhibits glucose‐6‐phosphate dehydrogenase (G6PD), reducing NADPH production and increasing oxidative stress, which can influence the onset and/or progression of several diseases, including cancer. 2‐Deoxy‐D‐glucose (2‐DG), a glucose mimetic, competes with glucose for cellular uptake, inhibiting glycolysis and competing with glucose‐6‐phosphate (G‐6‐P) for G6PD activity. In this study, we report that DHEA‐α‐2‐DG ( 5 ), an α‐covalent conjugate of DHEA and 2‐DG, exhibits better anticancer activity than DHEA, 2‐DG, DHEA +2‐DG, and polydatin in MCF‐7 cells, and reduces NADPH/NADP + ratio in cellular assays. In vitro enzyme kinetics and molecular docking studies showed that 5 uncompetitively inhibits human G6PD activity and binds to the structural NADP + site but not to the catalytic NADP + site. Further combining 5 with the FDA‐approved drug tamoxifen enhanced its cytotoxicity against MCF‐7 cells, suggesting that it could serve as a candidate for combination of drug strategies.

Subjects

MeSH terms (MEDLINE)

Antineoplastic AgentsBreast NeoplasmsEnzyme InhibitorsGlucosephosphate DehydrogenaseFemaleHumansDehydroepiandrosteroneDeoxyglucoseKineticsMCF-7 CellsMolecular Docking SimulationNADPTamoxifen

Author keywords

2‐deoxy‐D‐glucose (2‐DG)dehydropiandrosterone (DHEA)glucose‐6‐phosphate dehydrogenase (G6PD)glycolysispentose phosphate pathway (PPP)reduced nicotinamide adenine dinucleotide phosphate (NADPH)

Substances

Antineoplastic AgentsDehydroepiandrosteroneDeoxyglucoseEnzyme InhibitorsGlucosephosphate DehydrogenaseNADPTamoxifen

Authors and institutions

  • Department of Biological Science and Technology, National Yang Ming Chiao Tung University, Hsin-Chu, Taiwan.
  • Center for Emergent Functional Matter Science, National Yang Ming Chiao Tung University, Hsinchu, Taiwan.
  • Center for Intelligent Drug Systems and Smart Bio-Devices (IDS2B), National Yang Ming Chiao Tung University, Hsinchu, Taiwan.

Funding

  • National Science and Technology Council, Taiwan

Cite

APA

Liu, H. F., Chou, S. C., Huang, S. C., Huang, T. Y., Hsiao, P. Y., Chou, F. P., & Wu, T. K. (2024). Dehydroepiandrosterone‐α‐2‐Deoxyglucoside Exhibits Enhanced Anticancer Effects in MCF ‐7 Breast Cancer Cells and Inhibits Glucose‐6‐Phosphate Dehydrogenase Activity. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14624

Vancouver

Liu HF, Chou SC, Huang SC, Huang TY, Hsiao PY, Chou FP, et al. Dehydroepiandrosterone‐α‐2‐Deoxyglucoside Exhibits Enhanced Anticancer Effects in MCF ‐7 Breast Cancer Cells and Inhibits Glucose‐6‐Phosphate Dehydrogenase Activity. Chemical Biology & Drug Design. 2024. doi:10.1111/cbdd.14624

BibTeX
@article{Liu2024,
  author = {Liu, Hsu-Feng and Chou, Shen-Chieh and Huang, Sheng-Cih and Huang, Tzu-Yu and Hsiao, Po-Yun and Chou, Feng-Pai and Wu, Tung-Kung},
  title = {Dehydroepiandrosterone‐α‐2‐Deoxyglucoside Exhibits Enhanced Anticancer Effects in MCF ‐7 Breast Cancer Cells and Inhibits Glucose‐6‐Phosphate Dehydrogenase Activity},
  journal = {Chemical Biology & Drug Design},
  year = {2024},
  doi = {10.1111/cbdd.14624}
}
Start for free →